The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.50
Bid: 1,756.50
Ask: 1,757.00
Change: 0.50 (0.03%)
Spread: 0.50 (0.028%)
Open: 1,743.50
High: 1,759.00
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Asian data lifts stocks early on

Mon, 02nd Jul 2012 08:30

- Chinese, Japanese data comes in better than expected- RBS falls on Libor issues- Barclays Chairman resignsLondon's blue chips edged higher on Monday morning after manufacturing data in China and Japan boosted sentiment.China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last month, according to the National Bureau of Statistics and China Federation of Logistics and Purchasing, beating forecasts of around 49.9.Meanwhile, Japan's Tankan manufacturers' sentiment survey improved from minus four to minus one in the second quarter, compared to expectations of an unchanged ready.Investors will be looking ahead to policy decisions in both the UK and Europe around Thursday lunchtime. The Monetary Policy Committee (MPC) will be revealing its policy decision with the majority of economists expecting the Bank of England (BoE) to ramp up its asset purchase programme while keeping rates where they are.The European Central Bank (ECB) is anticipated to slash its main refinancing rate to a record-low 0.75%, compared with the current 1% level. 48 of the 71 economists surveyed by Reuters expect a reduction. FTSE 100: Banks continue to be dampened by Libor scandalRoyal Bank of Scotland (RBS) was a heavy faller after Oriel Securities downgraded its rating on the stock to 'hold'. It was revealed at the weekend that the bank had sacked four of its traders last year over the alleged manipulation of interbank lending rates (London Interbank Offered Rate, or LIBOR). Some market reports said that some 10 traders were dismissed, citing unidentified sources.The news comes after last week's revelation that banking peer Barclays had been fined £290m after it was found attempting to control submissions for LIBOR to benefit its interest rate derivatives. The issue prompted the lender's Chairman Marcus Agius to resign this morning. He said he is "truly sorry" that the bank's customers, clients, employees and shareholders have been let down. Barclay swung between gains and losses early on following last week's sell-off.Insurance group Aviva rose after announcing that Chairman Lord Sharman retired as Chairman on June 30th. John McFarlane has taken over.Pharmaceuticals giant AstraZeneca edged higher after saying that Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals will strengthen the leadership position of its diabetes alliance with Bristol-Myers in a "growing area of high unmet medical need". Astra will make a payment of $3.4bn in cash to Amylin once it becomes a wholly-owned subsidiary of Bristol-Myers.Sector peer GlaxoSmithKline also advanced after revealing positive results from four pivotal phase III studies for its once-daily COPD treatment. The company said that the results of the studies support its intention to commence global regulatory submissions for the treatment from the end of 2012.Serco, the international services company, rose after it signed an agreement to dispose of most of its operations in Germany in a transaction with the local management team.Media giant WPP was in demand after announcing another acquisition; it has agreed to acquire the South Korean media planning and buying agency, Alchemedia, which will be merged into its GroupM Korea subsidiary.FTSE 250: Catlin falls after broker downgradeInsurance group Catlin fell after Jefferies downgraded the stock to 'hold' as part of its review into the European insurance industry: "With Catlin now close to our price target, we downgrade to 'hold' also noting higher end US windstorm exposure and a broadly untouched reinsurance deductible."Oil and gas group SOCO International jumped after entering into a 'conditional' agreement with Lizeroux Oil & Gas to acquire the 20% minority interest in SOCO Vietnam that the group does not already own. FTSE 100 - RisersStandard Chartered (STAN) 1,418.50p +2.46%Barclays (BARC) 166.00p +1.93%WPP (WPP) 786.00p +1.68%Aviva (AV.) 276.80p +1.54%Burberry Group (BRBY) 1,345.00p +1.51%Prudential (PRU) 748.50p +1.42%Lloyds Banking Group (LLOY) 31.50p +1.27%BP (BP.) 427.20p +1.24%G4S (GFS) 282.40p +1.18%Tullow Oil (TLW) 1,487.00p +1.16%FTSE 100 - FallersXstrata (XTA) 780.20p -2.30%Shire Plc (SHP) 1,796.00p -1.97%Glencore International (GLEN) 290.45p -1.73%Royal Bank of Scotland Group (RBS) 211.70p -1.67%Tesco (TSCO) 306.45p -1.16%Vodafone Group (VOD) 177.45p -1.00%Evraz (EVR) 258.30p -0.92%British Sky Broadcasting Group (BSY) 690.50p -0.86%Smith & Nephew (SN.) 632.50p -0.78%International Consolidated Airlines Group SA (CDI) (IAG) 158.30p -0.75%FTSE 250 - RisersSoco International (SIA) 302.80p +4.63%Imagination Technologies Group (IMG) 487.60p +4.50%Aquarius Platinum Ltd. (AQP) 47.40p +3.81%Essar Energy (ESSR) 125.90p +3.20%Invensys (ISYS) 229.00p +2.83%BH Global Ltd. USD Shares (BHGU) 11.45 +2.69%Fenner (FENR) 370.70p +2.60%Shanks Group (SKS) 78.30p +2.55%FirstGroup (FGP) 229.40p +2.27%TR Property Inv Trust (TRY) 151.30p +2.23%FTSE 250 - FallersSpirit Pub Company (SPRT) 49.50p -2.46%Catlin Group Ltd. (CGL) 417.80p -1.81%Victrex (VCT) 1,249.00p -1.73%Cranswick (CWK) 801.00p -1.72%Halfords Group (HFD) 225.50p -1.61%New World Resources A Shares (NWR) 318.60p -1.51%Barr (A.G.) (BAG) 393.60p -1.40%Ruspetro (RPO) 133.40p -1.26%easyJet (EZJ) 525.50p -1.13%Renishaw (RSW) 1,386.00p -1.00%BC
More News
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.